In HD, the percentage of FoxP3+ cells is less dependent on the antibody clone used, and consistently 70–80% of CD4+CD25high cells express FoxP3, while in MS patients the fraction of FoxP3+ cells is generally lower. This evidence concerns the gene FOXP3 and myeloid sarcoma.